Interactions of attenuated Mycobacterium tuberculosis phoP mutant with human macrophages

Nadia L Ferrer1, Ana B Gomez, Olivier Neyrolles

  • 1Grupo de Genética de Micobacterias, Departamento de Microbiología, Medicina Preventiva y Salud Pública, Universidad de Zaragoza, Zaragoza, Spain.

Plos One
|October 2, 2010
PubMed
Abstract

Insights

The Mycobacterium tuberculosis phoP mutant SO2 shows increased binding to human macrophages and reduced intracellular growth, suggesting potential as an attenuated tuberculosis vaccine candidate.

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Background:

  • Mycobacterium tuberculosis (M. tuberculosis) phoP mutant SO2, derived from a clinical isolate, is attenuated in murine models.
  • This attenuation suggests SO2's potential as a live-attenuated vaccine candidate against tuberculosis.

Purpose of the Study:

  • To investigate the adhesion, intracellular replication, and trafficking of M. tuberculosis SO2 in human macrophages.
  • To compare SO2's behavior with the wild-type M. tuberculosis strain in a human cellular context.

Main Methods:

  • Analysis of SO2 adhesion to human monocyte-derived macrophages and THP-1 cells.
  • Assessment of intracellular replication and trafficking of SO2 within human macrophages.
  • Comparison of SO2 with wild-type M. tuberculosis regarding nitric oxide (NO) susceptibility.

Main Results:

  • SO2 exhibited enhanced adhesion to human phagocytic cells compared to the wild-type strain.
  • Impaired intracellular replication of SO2 was observed in both monocyte-derived macrophages and THP-1 cells.
  • Intracellular trafficking analysis indicated SO2 has an impaired ability to block phagosome-lysosome fusion.

Conclusions:

  • M. tuberculosis SO2 demonstrates enhanced binding to human macrophages and altered intracellular trafficking.
  • The study discusses the altered lipid profile and ESAT-6 secretion of the phoP mutant SO2 in relation to its attenuation.
  • Findings support SO2's potential as an attenuated vaccine candidate against tuberculosis.

Related Concept Videos

Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...